Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases.
Uehara
Y
Y
Fukazawa
H
H
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001358:Avian Sarcoma Viruses / Q000235:genetics; D016227:Benzoquinones; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D016391:Genes, src / Q000187:drug effects*; D006801:Humans; D047029:Lactams, Macrocyclic; D015688:Oncogene Protein pp60(v-src) / Q000037:antagonists & inhibitors*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011809:Quinones / Q000302:isolation & purification / Q000494:pharmacology*; D051381:Rats; D017828:Rifabutin / Q000031:analogs & derivatives; D013302:Streptomyces
D000903:Antibiotics, Antineoplastic; D016227:Benzoquinones; D047029:Lactams, Macrocyclic; D011809:Quinones; D017828:Rifabutin; C020754:herbimycin; D011505:Protein-Tyrosine Kinases; D015688:Oncogene Protein pp60(v-src)